Literature DB >> 20131004

Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.

Hansruedi Büeler1.   

Abstract

The structure and function of the mitochondrial network is regulated by mitochondrial biogenesis, fission, fusion, transport and degradation. A well-maintained balance of these processes (mitochondrial dynamics) is essential for neuronal signaling, plasticity and transmitter release. Core proteins of the mitochondrial dynamics machinery play important roles in the regulation of apoptosis, and mutations or abnormal expression of these factors are associated with inherited and age-dependent neurodegenerative disorders. In Parkinson's disease (PD), oxidative stress and mitochondrial dysfunction underlie the development of neuropathology. The recessive Parkinsonism-linked genes PTEN-induced kinase 1 (PINK1) and Parkin maintain mitochondrial integrity by regulating diverse aspects of mitochondrial function, including membrane potential, calcium homeostasis, cristae structure, respiratory activity, and mtDNA integrity. In addition, Parkin is crucial for autophagy-dependent clearance of dysfunctional mitochondria. In the absence of PINK1 or Parkin, cells often develop fragmented mitochondria. Whereas excessive fission may cause apoptosis, coordinated induction of fission and autophagy is believed to facilitate the removal of damaged mitochondria through mitophagy, and has been observed in some types of cells. Compensatory mechanisms may also occur in mice lacking PINK1 that, in contrast to cells and Drosophila, have only mild mitochondrial dysfunction and lack dopaminergic neuron loss. A better understanding of the relationship between the specific changes in mitochondrial dynamics/turnover and cell death will be instrumental to identify potentially neuroprotective pathways steering PINK1-deficient cells towards survival. Such pathways may be manipulated in the future by specific drugs to treat PD and perhaps other neurodegenerative disorders characterized by abnormal mitochondrial function and dynamics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20131004     DOI: 10.1007/s10495-010-0465-0

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  32 in total

Review 1.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 3.  Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle.

Authors:  Joshua C Drake; Rebecca J Wilson; Zhen Yan
Journal:  FASEB J       Date:  2015-09-14       Impact factor: 5.191

Review 4.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  Monitoring mitophagy in neuronal cell cultures.

Authors:  Jianhui Zhu; Ruben K Dagda; Charleen T Chu
Journal:  Methods Mol Biol       Date:  2011

6.  Inhibition effects of scorpion venom extracts (Buthus matensii Karsch) on the growth of human breast cancer MCF-7 cells.

Authors:  Weiling Li; Ye Li; Yuwan Zhao; Jieli Yuan; Weifeng Mao
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

Review 7.  Mitophagy in ischaemia/reperfusion induced cerebral injury.

Authors:  Kangyong Liu; Yinyi Sun; Zhaohua Gu; Nan Shi; Ting Zhang; Xiaojiang Sun
Journal:  Neurochem Res       Date:  2013-04-07       Impact factor: 3.996

Review 8.  Mitochondrial remodeling: Rearranging, recycling, and reprogramming.

Authors:  Roberta A Gottlieb; Daniel Bernstein
Journal:  Cell Calcium       Date:  2016-04-20       Impact factor: 6.817

Review 9.  Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson's Disease: Therapeutic Rationale and Current Status.

Authors:  Tara Swart; Michael J Hurley
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

10.  Omega-3 and omega-6 fatty acids suppress ER- and oxidative stress in cultured neurons and neuronal progenitor cells from mice lacking PPT1.

Authors:  Sung-Jo Kim; Zhongjian Zhang; Arjun Saha; Chinmoy Sarkar; Zhenwen Zhao; Yan Xu; Anil B Mukherjee
Journal:  Neurosci Lett       Date:  2010-06-04       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.